Product phospholipids -lipids-for-drug-delivery

Home > products > phospholipids > lipids-for-drug-delivery

Catalog	name	Description	price
R-C-0003	Dimethyldioctadecylammonium bromide,CAS:3700-67-2	Dimethyldioctadecylammonium bromide，DODAB,DDAB from ruixi. Dimethyldioctadecylammonium bromide is a synthetic double chain cationic surfactant with a simple structure similar to phospholipid, the main component of cell membrane. Therefore, DODAB and its analogues are often used to simulate the biochemical process of biofilm.	price>
R-C-4671	SM-102 CAS:2089251-47-6	SM-102 is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles. Administration of luciferase mRNA in SM-102-containing lipid nanoparticles induces hepatic luciferase expression in mice. Formulations containing SM-102 have been used in the development of lipid nanoparticles for delivery of mRNA-based vaccines.	price>
R-C-6842	Cellsome Phosphatidylserine(PS)-based(DOPS:DOPC (20:80 molar ratio))	Cellsome Phosphatidylserine(PS)-based(DOPS:DOPC (20:80 molar ratio)),Liposomes are extensively used to study the interaction of proteins, peptides and other molecules with the surface of a lipid membrane.One of the parameters that affects this interaction is the charge of the liposomal membrane.Phosphatidylserine(PS)is a negatively charged molecule.The matrix lipid DOPC that is used in the formulations does not significantly contribute to the charge of the liposomes.Anionic liposomes are used in blood complement studies and various types of in vitro studies.	price>
R-C-6758	Surface Reactive Doxorubicin Liposomes-Succinyl(PEGylated)	Surface Reactive Doxorubicin Liposomes-Succinyl(PEGylated)represent an advanced method of drug delivery that combines nanotechnology and biochemical modifications to improve cancer treatment outcomes.Through targeted delivery,extended circulation time,and reduced toxicity,this formulation has the potential to enhance the therapeutic index of doxorubicin in cancer treatment.	price>
R-C-6759	Surface Reactive Doxorubicin Liposomes-Carboxylic Acid (PEGylated)	Surface Reactive Doxorubicin Liposomes-Carboxylic Acid(PEGylated)are a specialized formulation designed for the targeted delivery of the chemotherapeutic drug doxorubicin.This formulation leverages the advantages of liposome technology, chemical modifications,and advanced targeting strategies to improve the efficacy and safety of cancer treatment.Below is a comprehensive overview of the components,characteristics,and potential applications of this formulation.	price>
R-C-6760	Surface Reactive Doxorubicin Liposomes-Amine (PEGylated)	Surface Reactive Doxorubicin Liposomes-NH2(PEGylated)are advanced drug delivery systems designed for the targeted delivery of the chemotherapeutic agent doxorubicin,utilizing a combination of liposome technology and surface modification techniques.This formulation aims to improve the pharmacokinetics and therapeutic efficacy of doxorubicin while minimizing its side effects.	price>
R-C-6761	Surface Reactive Doxorubicin Liposomes-PDP(PEGylated)	Surface Reactive Doxorubicin Liposomes-PDP(PEGylated)are an advanced formulation designed for targeted delivery of the chemotherapeutic agent doxorubicin using liposomes that incorporate a specific functionalization strategy,likely employed for improved targeting and therapeutic efficacy.This formulation leverages liposomal technology,polyethylene glycol(PEG) modification,and a functional group such as PDP(likely referring to a type of peptide or polymer)for enhanced drug delivery characteristics.	price>
R-C-6762	Surface Reactive Doxorubicin Liposomes-Azide (PEGylated)	Surface Reactive Doxorubicin Liposomes-Azide(PEGylated)are a sophisticated formulation designed for targeted delivery of doxorubicin,a widely used chemotherapeutic agent,utilizing liposome technology.The incorporation of azide functional groups highlights the advanced capabilities of bioorthogonal chemistry,facilitating enhanced therapeutic targeting,imaging,or combination therapies.	price>
R-C-6763	Surface Reactive Doxorubicin Liposomes-Biotin (PEGylated)	Surface Reactive Doxorubicin Liposomes-Biotin(PEGylated)are a sophisticated drug delivery system designed to enhance the targeting and therapeutic efficiency of doxorubicin,a widely used chemotherapeutic agent.The incorporation of biotin and PEGylation in the liposomal structure provides specific advantages in cancer therapy,allowing for improved delivery and reduced side effects.	price>
R-C-6764	Surface Reactive Doxorubicin Liposomes-FA (PEGylated)	Surface Reactive Doxorubicin Liposomes-Folate(PEGylated)represent a promising strategy in cancer therapy.By integrating the design features of liposomes,the benefits of PEGylation,and the targeting capability of folate functionalization,this formulation aims to enhance the effectiveness of doxorubicin while minimizing the unwanted side effects often associated with chemotherapy.Future investigations,including clinical trials,will be essential to validate the therapeutic potential and safety of this targeted drug delivery system in various oncological settings.	price>

...